Epistaxis, or nosebleed, is a common phenomenon. It is usually self-limiting, of limited clinical significance and can often be managed in the primary care setting. However, it may also be the first presentation of more serious head and neck pathology and in some patients may lead to more significant clinical sequelae. GPs should have an understanding of the management of acute and recurrent epistaxis, and need to be able to identify aetiological factors and complications. Careful assessment and prompt intervention is required in all patients to avoid more serious outcomes.
Get full access to this article
View all access options for this article.
References
1.
BadranK., MalikT. H., BellosoA., & TimmsM. S. (2005). Randomised controlled trial comparing Merocel and RapidRhino packing in the management of epistaxis.Clinical Otolaryngology, 30(4), 333-337. doi: 10.1111/j.1365-2273.2005. 01019.x
DaudiaA., JaiswalV., & JonesN. S. (2008). Guidelines for the management of idiopathic epistaxis in adults: how we do it.Clinical Otolaryngology33(6), 618-620. doi: 10.1111/j.1749-4486.2008.01795x
4.
KucikC. J., & ClenneyT. (2005). Management of epistaxis.American Family Physician, 77 (2), 305-311. Retrieved from www.aafp.org/afp/2005/0115/p305.html
5.
McintoshN., MokJ. Y, & MargerisonA. (2007). Epidemiology of oronasal haemorrhage in the first 2 years of life: implications for child protection.Pediatrics, 720(5), 1044-1048. doi: 10.1542/peds.2007-2097
6.
MoumoulidisI., DraperM. R., PatelH., JaniP., & PriceT. (2006). A prospective randomised controlled trial comparing Merocel and RapidRhino nasal tampons in the treatment of epistaxis.European Archives of Oto-rhino-laryngology, 263(8), 719-722.
